Skip to Main Content

File this under “not ready for prime time.”

The US Food and Drug Administration scolded two drug makers for using loud music and fast-paced visuals in their television ads that obscured important risk information.


In both cases, the agency contended the techniques would distract consumers being able to adequately comprehend and process effect warnings, according to a pair of letters sent on Monday to the drug makers. One letter was sent to Celgene over concerns for an ad promoting its Otezla psoriasis pill and the other was sent to Sanofi expressing dissatisfaction with an ad for its Toujeo diabetes treatment.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!


Comments are closed.